Lv5
820 积分 2023-02-28 加入
Review article: drug‐induced liver injury in the context of nonalcoholic fatty liver disease – a physiopathological and clinical integrated view
2天前
已完结
Diagnosis and management of metabolic dysfunction associated steatotic liver disease
20天前
已完结
Liver organoids from hepatocytes of healthy humans and non-alcoholic fatty liver disease (NAFLD) patients display multi-lineage architecture and can be used to develop an in vitro model of steatohepatitis
20天前
已完结
Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model
27天前
已完结
Modeling Human Nonalcoholic Fatty Liver Disease (NAFLD) with an Organoids-on-a-Chip System
1个月前
已完结
TSG attenuated NAFLD and facilitated weight loss in HFD-fed mice via activating the RUNX1/FGF21 signaling axis
1个月前
已完结
Is liver regeneration key in hepatocellular carcinoma development?
1个月前
已完结
Molecular Pathways Governing the Termination of Liver Regeneration
1个月前
已完结
LEADS – a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing
1个月前
已完结
Review article: drug‐induced liver injury in the context of nonalcoholic fatty liver disease – a physiopathological and clinical integrated view
1个月前
已完结
皖公网安备34019202002308
